Skip to main content

Table 6 Univariate sensitivity analysis of screening, abnormal findings management and treatment costs (€), Italy 2006.

From: Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

  Screening Abnormal findings and treatment Total costs of cervical cancer prevention
Baseline values for all the parameters 158,288,703 22,959,267 181,247,970
No. of screened women yearly    
   baseline: extrapolation from ISTAT (N = 6,423,924)    
   lower case: similar, but excluding overlap between opportunistic and organised screening (N = 6,270,130) 154,332,393 22,825,230 177,157,624
No. of CIN2/3 found    
   baseline: estimate from Emilia Romagna cancer registry (N = 6,982)    
   higher case: extrapolation from GISCi survey (N = 16,571) 158,288,703 34,532,811 192,821,515
Referral rate    
   baseline: extrapolation from GISCi survey (2.5%)    
   lower case: 25th centile of the GISCi survey distribution (1.5%) 158,288,703 20,920,849 179,209,552
   higher case: 75th centile of the GISCi survey distribution (3%) 158,288,703 24,235,135 182,523,838
ASCUS management    
   baseline: no triage with HPV test    
   triage with HPV test (cost 81.60€ according to national tariff) 158,288,703 26,101,216 184,389,919
   triage with HPV test (cost 15.00€) 158,288,703 22,197,251 180,485,954
Colposcopy setting    
   baseline: no gynaecological visit    
   upper case: gynaecological visit for colposcopies performed in opportunistic screening 158,288,703 25,199,706 183, 488,409
CIN1 treatment    
   baseline: 37% of CIN1 treated    
   upper case: 63% of CIN1 treated 158,288,703 26,231,936 184,510,639
Conisation setting    
   baseline: inpatient (36% day hospital and 64% full hospitalization)    
   lower case: outpatient 158,288,703 8,084,711 166,373,414
\